Skip to content

Tuesday, November 5, 2024

Latest:

How to cope when your pet dies
Medical residency and advocacy: Even small contributions can have a significant impact
Medical student-mentor teams in research: Shubh Desai and Dr. Nandan Mondal share their experience with SOAR
What is fracture-related infection? Causes, symptoms and treatment options
Innovative surgical procedure reduces risk of lymphedema for breast cancer patients

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

HEROS clinical trial

nci-ewing-sarcoma

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial

May 21, 2024 CARTcell therapy, HEROS clinical trial, Research, sarcoma

The HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit.

From the Labs: Image of the Month

From the Labs: Aging signs.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951